Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Lung Nodule Assessment and Comparison Option (LNA)

K-Number: K162484 · 2017-02-23

ApplicantPhilips Medical Systems Nederland B.V.
Decision Date2017-02-23
Product CodeLLZ
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

Lung Nodule Assessment and Comparison Option (LNA) is a medical device manufactured by Philips Medical Systems Nederland B.V.. It received FDA 510(k) clearance on 2017-02-23 under approval number K162484. The device is classified under product code LLZ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Lung Nodule Assessment and Comparison Option (LNA)?

Lung Nodule Assessment and Comparison Option (LNA) is a medical device that received FDA 510(k) clearance on 2017-02-23. It is manufactured by Philips Medical Systems Nederland B.V.. The 510(k) number is K162484.

When was Lung Nodule Assessment and Comparison Option (LNA) approved by the FDA?

Lung Nodule Assessment and Comparison Option (LNA) received FDA 510(k) clearance on 2017-02-23, under approval number K162484.

What company makes Lung Nodule Assessment and Comparison Option (LNA)?

Lung Nodule Assessment and Comparison Option (LNA) is manufactured by Philips Medical Systems Nederland B.V..

What is the FDA product code for Lung Nodule Assessment and Comparison Option (LNA)?

The FDA product code for Lung Nodule Assessment and Comparison Option (LNA) is LLZ.

Related Clinical Trials

NCT07613944 Ultrasound Assessment of Tongue Characteristics in Adolescents With Obesity and Obstructive Sleep Disorders NOT_YET_RECRUITING NCT07604922 Investigating Vascular Properties of HEMI and SPG Signals in Individuals With or at Risk for Chronic Kidney Disease NOT_YET_RECRUITING NCT07605234 Phase II Single Arm Open Label Study Evaluating the Feasibility and Safety of Photobiomodulation as an Adjunct to Standard Supportive Care for Chemotherapy Induced Oral Mucositis in Pediatric Patients With Hematolymphoid Malignancies NOT_YET_RECRUITING NCT07599124 Effectiveness of Light Therapy Across Seasons COMPLETED NCT06557538 A Comparison of Automatic ABPI vs Manual ABPI Device Scores COMPLETED NCT07299006 Evaluation of Paro, a Therapeutic Assistance Robot in Analgesic Management During the Placement of a Peripheral Intravenous Line in Infants and Children. RECRUITING

Related PubMed Literature

PMID: 41265798 Comparison of two models of biofilm formation on reusable stainless steel medical device material. The Journal of hospital infection (2026)

Other Devices by Philips Medical Systems Nederland B.V.

K162940MultiBand SENSE K162955Multi-Modality Tumor Tracking (MMTT) application K162859Allura Xper FD series and Allura Xper OR Table series K160455AneurysmFlow K160147CT TrueView K1618392D Quantitative Analysis

View all 77 devices →

Related Devices (Code: LLZ)

K161959ClearView cCADClearview Diagnostics, Inc. K163539Ez3D-i / E3Ewoosoft Co., Ltd. K162955Multi-Modality Tumor Tracking (MMTT) applicationPhilips Medical Systems Nederland B.V. K160852ZiaZetta Medical Technologies, LLC K162376CAAS MR 4D FlowPie Medical Imaging BV K161322CT CoPilotZepmed, LLC

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑